Streetbeat News

Equity Actions

AVGO

Broadcom Inc. (NYSE:AVGO) has seen a 17.62% decrease in short interest since its last report, with 7.44 million shares sold short, representing 1.73% of its float. The average time to cover these short positions is 3.75 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Broadcom's short interest is below its peer group average of 3.71%. While a decline in short interest does not necessarily predict a rise in stock price, it suggests fewer traders are betting against the stock.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 5:00 pm

CRWD

CrowdStrike Holdings (NYSE:CRWD) has seen a 14.29% increase in short interest since the last report, with 6.15 million shares sold short, representing 2.8% of available shares. It would take about 2.25 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, CRWD has less short interest compared to its peers' average of 4.76%. The rise in short interest doesn't necessarily predict a price drop.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 5:00 pm

INTC

Intel Corporation (NYSE:INTC) has seen a 25.19% increase in short interest since its last report, with 71.29 million shares sold short, representing 1.69% of available shares. The average time to cover these short positions is 1.97 days. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop. Intel's short interest is below its peer group average of 3.71%.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 5:00 pm

ADP

Automatic Data Processing (NASDAQ:ADP) is analyzed against competitors in the Professional Services industry. ADP shows favorable growth potential with a PE ratio slightly below the industry average, a low PB ratio suggesting undervaluation, and a high PS ratio indicating potential overvaluation. The company's ROE, EBITDA, gross profit, and revenue growth are all significantly above industry averages, demonstrating strong financial performance. ADP's lower debt-to-equity ratio compared to its top 4 peers suggests a stronger financial position with less reliance on debt.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 4:00 pm

ADBE

The article provides a detailed comparison of Adobe (NASDAQ:ADBE) with its competitors in the Software industry, analyzing financial metrics such as P/E, P/B, P/S, ROE, EBITDA, gross profit, and revenue growth. Adobe's P/E ratio is below the industry average, suggesting potential for growth, while its P/B ratio indicates possible undervaluation. However, its P/S ratio is higher than the industry average, which could imply overvaluation relative to sales. Adobe's ROE is below the industry average, suggesting inefficiency, but its EBITDA and gross profit are significantly above the industry average, indicating strong profitability. Adobe's revenue growth is lower than the industry average, potentially signaling a decline in sales performance. The company's lower debt-to-equity ratio compared to its top 4 peers suggests a stronger financial position with less reliance on debt financing.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 4:00 pm

ORCL

Oracle (NYSE:ORCL) has seen unusual options activity with a bullish sentiment from financial giants, with 75% of traders being bullish. Analysis of options history revealed 8 trades, with 6 puts valued at $434,550 and 2 calls valued at $89,200. The predicted price range for Oracle over the next three months is $80.0 to $130.0. The volume and open interest for options within this range have been analyzed, with significant trades listed. Oracle's current stock price is $112.4, up by 0.33%, with a neutral RSI indicator and an earnings announcement expected in 4 days.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 3:46 pm

1357.HK

Meitu Inc. has completed a spinoff and funding round for its Singapore-based Pixocial unit, raising $22 million from investors including Fidelity's Eight Roads, valuing Pixocial at over $100 million. Pixocial, which contributed significantly to Meitu's 2022 net income, is now 80.6% owned by Meitu. The funding and spinoff may set Pixocial up for an IPO, with Meitu's stock rising nearly 7% post-announcement. Pixocial will focus on expanding its subscription services and B2B SaaS platform for creatives internationally.

Portfolio Pulse from The Bamboo Works

December 07, 2023 | 3:32 pm

META

MSFT

The article compares the stock performance of Microsoft (MSFT) and Meta Platforms (META), formerly Facebook, from May 18, 2012, to November 29, 2023. A $1,000 investment in Microsoft in 2012 would have grown to approximately $12,951, while the same amount in Meta would have become about $8,687. Microsoft outperformed Meta by roughly $4,300 over the 11-year period. The article suggests that both companies are worth watching for future investment opportunities and also mentions the potential of investing in startups.

Portfolio Pulse from Chris Bibey

December 07, 2023 | 3:24 pm

GSK

WVE

Wave Life Sciences Ltd (NASDAQ:WVE) is trading lower after pricing its public offering of 20 million shares at $5.00 per share, aiming to raise approximately $100 million. The underwriters have a 30-day option to purchase up to an additional 3 million shares. The offering is expected to close around December 11. Wave Life Sciences also initiated dosing in the RestorAATion clinical trial for WVE-006, a potential treatment for alpha-1 antitrypsin deficiency (AATD), and received a $20 million milestone payment from GSK plc (NYSE:GSK) as part of their collaboration. Wave is eligible for up to $505 million more in milestone payments and royalties from GSK. WVE shares dropped 29.40% to $4.85.

Portfolio Pulse from Vandana Singh

December 07, 2023 | 3:08 pm

GILD

Gilead Sciences Inc. (NASDAQ:GILD) shares are trading at $79.44, with a 0.10% increase in the current session and a 5.57% increase over the past month, despite a 10.01% decline over the past year. The stock's P/E ratio of 17.0 is lower than the Biotechnology industry average of 36.66, suggesting it may be undervalued or expected to perform worse than its peers.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 3:00 pm